Canada Exercises Increased Option for Total of 40 Million Doses of mRNA Vaccine Candidate Against COVID-19 (mRNA-1273) 08/12/2020 mediabest Medications CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 7, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create Read more